Red blood cells contribution in blood coagulation
- Authors: Chabin I.A.1,2, Podoplelova N.A.1,3, Panteleev M.A.1,3
-
Affiliations:
- Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
- Sechenov First Moscow State Medical University (Sechenov University)
- Center for Theoretical Problems of Physicochemical Pharmacology, Russian Academy of Sciences
- Issue: Vol 21, No 3 (2022)
- Pages: 136-141
- Section: LITERATURE REVIEW
- Submitted: 15.10.2022
- Accepted: 15.10.2022
- Published: 15.10.2022
- URL: https://hemoncim.com/jour/article/view/659
- DOI: https://doi.org/10.24287/1726-1708-2022-21-3-136-141
- ID: 659
Cite item
Full Text
Abstract
For a long time, red blood cells have been known to have a procoagulant effect on hemostatic system. This effect was usually ascribed to either general increase of blood viscosity due to increased hematocrit value, RBCs' transport-enhancing effect on platelets adhesion under flow conditions. It is known that red blood cells can have a procoagulant effect on the hemostasis system. This effect is usually explained either by a general increase in blood viscosity due to an increase in hematocrit, or by the effect of red blood cells on the transport of platelets to the vessel wall and their further adhesion. However, recent studies indicate that the role of red blood cells in blood coagulation is much wider. In this review, we will consider the main mechanisms currently known, through which red blood cells can influence the processes of hemostasis and thrombosis in normal and pathological conditions.
Keywords
About the authors
I. A. Chabin
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation; Sechenov First Moscow State Medical University (Sechenov University)
Moscow
Russian FederationN. A. Podoplelova
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation; Center for Theoretical Problems of Physicochemical Pharmacology, Russian Academy of Sciences
Author for correspondence.
Email: podoplelovan@yandex.ru
Nadezhda A. Podoplelova, PhD, leading researcher of the Laboratory of Cell Hemostasis and Thrombosis
1 Samory Mashela St., Moscow 117997, Russia
Russian FederationM. A. Panteleev
Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation; Center for Theoretical Problems of Physicochemical Pharmacology, Russian Academy of Sciences
Moscow
Russian FederationReferences
Supplementary files
